NPI: 1760993034 · MC KENZIE, TN 38201 · Clinical Medical Laboratory · NPI assigned 10/13/2017
Authorized official WILLIAMS, KIMBERLY controls 20+ related entities in our dataset. Read more
| Authorized Official | WILLIAMS, KIMBERLY (VICE PRESIDENT) |
| NPI Enumeration Date | 10/13/2017 |
Other providers sharing the same authorized official: WILLIAMS, KIMBERLY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 17,569 | $44K |
| 2019 | 70,637 | $228K |
| 2020 | 46,994 | $99K |
| 2021 | 54,792 | $113K |
| 2022 | 52,753 | $124K |
| 2023 | 57,035 | $170K |
| 2024 | 28,707 | $120K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 80050 | General health panel | 12,510 | 9,876 | $157K |
| 80061 | Lipid panel | 32,687 | 25,991 | $85K |
| 80053 | Comprehensive metabolic panel | 35,330 | 28,376 | $72K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 29,909 | 23,811 | $63K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 24,275 | 20,250 | $53K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 8,495 | 6,458 | $48K |
| 84443 | Thyroid stimulating hormone (TSH) | 15,005 | 11,740 | $35K |
| 83036 | Hemoglobin; glycosylated (A1C) | 21,486 | 17,154 | $35K |
| 87186 | 8,217 | 7,003 | $20K | |
| 36415 | Collection of venous blood by venipuncture | 8,138 | 6,808 | $15K |
| 82607 | 5,902 | 4,428 | $15K | |
| 81025 | 4,142 | 2,847 | $15K | |
| 87088 | 7,495 | 6,362 | $15K | |
| 84439 | 7,824 | 6,134 | $15K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 8,290 | 6,427 | $14K |
| 82728 | 4,727 | 3,627 | $11K | |
| 83880 | 1,451 | 1,121 | $10K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 570 | 275 | $10K |
| 84702 | 1,898 | 1,314 | $8K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 369 | 318 | $8K |
| 85027 | 5,515 | 4,496 | $8K | |
| 84153 | 2,603 | 2,026 | $8K | |
| 82746 | 2,881 | 2,159 | $7K | |
| 83550 | 5,005 | 3,831 | $7K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 765 | 633 | $7K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 758 | 630 | $7K |
| 82570 | 5,028 | 4,042 | $6K | |
| 87077 | 3,506 | 2,997 | $6K | |
| 87070 | 2,780 | 2,419 | $6K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 259 | 246 | $6K |
| 83540 | 5,322 | 4,064 | $6K | |
| 87081 | 2,220 | 1,944 | $5K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 521 | 443 | $5K |
| 81003 | 8,527 | 6,485 | $5K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1,078 | 720 | $5K |
| 87807 | 829 | 697 | $5K | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 30 | 22 | $5K |
| 83735 | 2,625 | 1,937 | $4K | |
| 85610 | 3,375 | 2,208 | $4K | |
| 84403 | 670 | 488 | $4K | |
| 80074 | 909 | 628 | $4K | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 127 | 116 | $4K |
| 82043 | 4,270 | 3,393 | $4K | |
| 80055 | 309 | 202 | $4K | |
| 82247 | 1,525 | 1,179 | $3K | |
| 81001 | 3,174 | 2,741 | $3K | |
| 83690 | 984 | 824 | $2K | |
| 86140 | 2,038 | 1,531 | $2K | |
| 83655 | 344 | 325 | $2K | |
| 86803 | 664 | 515 | $2K | |
| 86850 | 333 | 313 | $2K | |
| 82248 | 1,043 | 812 | $2K | |
| 84481 | 574 | 454 | $2K | |
| 85652 | 1,948 | 1,569 | $2K | |
| 83001 | 311 | 233 | $2K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 99 | 93 | $2K |
| 82670 | 181 | 143 | $1K | |
| 87522 | Neg quan hep c or qual rna | 104 | 91 | $1K |
| 82150 | 647 | 525 | $1K | |
| 84436 | 1,144 | 833 | $1K | |
| 84550 | 1,507 | 1,254 | $1K | |
| 87420 | 216 | 203 | $1K | |
| 86003 | 111 | 74 | $1K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 147 | 137 | $1K |
| 83970 | 204 | 148 | $1K | |
| 87902 | 19 | 15 | $1K | |
| 83002 | 239 | 179 | $1K | |
| 86757 | 112 | 97 | $1K | |
| 84146 | 235 | 173 | $1K | |
| 84156 | 880 | 748 | $1K | |
| 84479 | 813 | 590 | $946.50 | |
| 87536 | 17 | 16 | $896.74 | |
| 88141 | 152 | 146 | $809.47 | |
| 81329 | 26 | 20 | $783.83 | |
| 86618 | 88 | 79 | $713.78 | |
| 82465 | 451 | 371 | $675.46 | |
| 83516 | 109 | 97 | $657.23 | |
| 86900 | 369 | 343 | $573.05 | |
| 86901 | 369 | 343 | $570.95 | |
| 87210 | 361 | 270 | $559.28 | |
| 84144 | 112 | 87 | $549.76 | |
| 83615 | 387 | 319 | $501.87 | |
| 86592 | 612 | 426 | $492.96 | |
| 83525 | 206 | 165 | $491.69 | |
| 86038 | 255 | 191 | $483.87 | |
| 87340 | 192 | 162 | $428.18 | |
| 86696 | 142 | 100 | $407.94 | |
| 84402 | 66 | 45 | $392.16 | |
| 84450 | 284 | 217 | $337.78 | |
| 82565 | 209 | 162 | $334.23 | |
| 82105 | 205 | 131 | $326.40 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 38 | 28 | $311.68 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 23 | 17 | $309.52 |
| 82784 | 68 | 55 | $301.20 | |
| 82677 | 65 | 35 | $294.15 | |
| 84681 | 72 | 48 | $284.43 | |
| 84480 | 127 | 93 | $248.01 | |
| 83021 | 47 | 31 | $247.62 | |
| 82627 | 34 | 21 | $236.98 | |
| 86695 | 139 | 97 | $235.18 | |
| 84460 | 225 | 161 | $210.42 | |
| 86336 | 68 | 37 | $189.45 | |
| 86200 | 91 | 81 | $176.20 | |
| 86617 | 16 | 15 | $175.84 | |
| 86431 | 210 | 160 | $173.40 | |
| 82785 | 20 | 18 | $160.20 | |
| 82950 | 114 | 101 | $153.03 | |
| 84075 | 181 | 133 | $149.71 | |
| 80076 | 89 | 67 | $136.30 | |
| 86666 | 17 | 15 | $132.00 | |
| 82040 | 189 | 134 | $126.81 | |
| 85730 | 97 | 77 | $122.34 | |
| 82140 | 21 | 17 | $117.85 | |
| 86255 | 41 | 31 | $117.24 | |
| 85018 | 202 | 151 | $114.80 | |
| 86376 | 91 | 71 | $104.48 | |
| 84484 | 26 | 24 | $103.50 | |
| 84100 | 94 | 69 | $101.73 | |
| G0306 | Complete cbc, automated (hgb, hct, rbc, wbc, without platelet count) and automated wbc differential count | 81 | 66 | $85.83 |
| 85660 | 42 | 30 | $84.60 | |
| 85045 | 147 | 91 | $66.93 | |
| 86225 | 31 | 28 | $66.78 | |
| S3600 | Stat laboratory request (situations other than s3601) | 2,209 | 1,731 | $56.58 |
| 85014 | 152 | 106 | $54.78 | |
| 82378 | 15 | 12 | $52.76 | |
| 84132 | 38 | 25 | $44.22 | |
| 86704 | 16 | 14 | $39.08 | |
| 82550 | 32 | 27 | $31.54 | |
| 87075 | 13 | 13 | $31.02 | |
| 86706 | 34 | 29 | $29.85 | |
| 85379 | 20 | 17 | $29.72 | |
| 82947 | 13 | 12 | $25.52 | |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | 12 | 12 | $24.62 |
| 82977 | 34 | 20 | $20.00 | |
| 80069 | 16 | 14 | $11.20 | |
| 85041 | 27 | 12 | $7.29 | |
| 85048 | 27 | 12 | $6.15 | |
| 80164 | 15 | 13 | $5.78 | |
| 86800 | 36 | 32 | $5.56 | |
| 36416 | 65 | 50 | $0.15 | |
| 80177 | 15 | 13 | $0.00 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 137 | 113 | $0.00 |
| 86235 | 15 | 15 | $0.00 |